Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.As of 9 Jun 2026, INDRAPRASTHA MEDICAL CORP share price is ₹393.25. The stock opened at ₹390.00, compared to its previous close of ₹389.65. During today's trading session, INDRAPRASTHA MEDICAL CORP share price moved in the range of ₹389.50 to ₹394.55, with an average price of ₹392.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹389.50 and a high of ₹394.55. On the performance front, INDRAPRASTHA MEDICAL CORP share price has declined by 14.06% over the last six months and is down 9.40% on a year-on-year basis.
The market capitalization of INDRAPRASTHA MEDICAL CORP is ₹3,626 Crs, with a P/E ratio of 19.8 and a dividend yield of 1.03%.